02898.HK
Sunho Biologics, Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 6.40
+0.00%Margins
Gross margin
100.0%
EBITDA margin
-6174.7%
EBIT margin
-7452.4%
Net margin
-8525.8%
FCF margin
-7712.6%
-36.5%
Return on equity
-31.5%
Return on assets
-27.9%
Return on invested capital
0.00x
Asset turnover
-HKD 138.7M
Cash from operations
HKD 3.41
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2025